摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methoxy-2-[(2-ethoxyethyl)sulfinyl]benzimidazole | 137811-09-7

中文名称
——
中文别名
——
英文名称
5-methoxy-2-[(2-ethoxyethyl)sulfinyl]benzimidazole
英文别名
2-(2-ethoxyethylsulfinyl)-6-methoxy-1H-benzimidazole
5-methoxy-2-[(2-ethoxyethyl)sulfinyl]benzimidazole化学式
CAS
137811-09-7
化学式
C12H16N2O3S
mdl
——
分子量
268.337
InChiKey
HSCFORQUFJWDSP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    83.4
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Thiazole and imidazole derivatives and antiulcer composition containing same
    申请人:MEIJI SEIKA KABUSHIKI KAISHA
    公开号:EP0452076A1
    公开(公告)日:1991-10-16
    A thiazole or imidazole derivative having the general formula (I): wherein: R¹ and R², which may be the same or different, each independently represent a hydrogen atom, or a phenyl or heteroaryl group, or R¹ and R² may together form a benzene ring which may be optionally substituted by a halogen atom or a lower alkyl optionally substituted by a halogen atom, lower alkoxy or nitro group; A represents a sulfur atom or -NH-; B represents a lower alkoxy group optionally substituted by a halogen atom; a five- or six-membered saturated heterocyclic ring containing one nitrogen or oxygen atom which ring may be optionally substituted; a six-membered saturated heterocyclic ring containing one oxygen atom plus one nitrogen atom; a group -XR³ where X represents a group -NR⁴ wherein R³ and R⁴, which may be the same or different, each independently represent a lower alkyl group; or a group -NHC(=Y)R⁵ where Y represents an oxygen or sulfur atom or a group =NCN or =CHNO₂, and R⁵ represents a group -NHR⁶ or -SR⁶ wherein R⁶ represents a lower alkyl group optionally substituted by a halogen atom; m is an integer from 1 to 4; and n is an integer from 0 to 2; and their pharmacologically acceptable salts. The compounds has an antiulcerative activity.
    具有通式 (I) 的噻唑咪唑生物: 其中 R¹和 R²(可以相同或不同)各自独立地代表一个氢原子,或一个苯基或杂芳基,或 R¹和 R²可共同形成一个苯环,该苯环可任选被卤素原子或任选被卤素原子、低级烷氧基或硝基取代的低级烷基取代; A 代表原子或-NH-; B 代表可任选被卤素原子取代的低级烷氧基; 包含一个氮原子或氧原子的五元或六元饱和杂环,该环可任选被取代; 包含一个氧原子加一个氮原子的六元饱和杂环;基团 -XR³ 其中 X 代表基团 -NR⁴ 其中 R³ 和 R⁴ 可以相同或不同,各自独立地代表低级烷基;或基团 -NHC(=Y)R⁵ 其中 Y 代表氧原子或原子或基团 =NCN 或 =CHNO₂,且 R⁵ 代表基团 -NHR⁶ 或 -SR⁶,其中 R⁶ 代表任选被卤原子取代的低级烷基; m 是 1 至 4 的整数;以及 n 是 0 至 2 的整数; 及其药理学上可接受的盐类。这些化合物具有抗溃疡活性。
  • ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE, AND A METHOD FOR OBTAINING AND THE USE OF SAID ACTIVE SUBSTANCE
    申请人:Ivashchenko Andrey Alexandrovich
    公开号:US20110245231A1
    公开(公告)日:2011-10-06
    The invention relates to novel drug substance for the treatment of alcohol dependence, pharmaceutical composition, medicament and method for treatment of dependence on using ethyl alcohol containing beverages. The invention provides a drug substance for treating alcohol dependence in human and warm-blooded animals representing substituted 1H-benzimidazoles of the general formula 1 or pharmaceutically acceptable salts and/or hydrates thereof wherein: W represents S or S═0 group; R 1 represents one or more substituent selected from hydrogen, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, optionally substituted azaheterocyclyl; R 2 represents hydrogen or optionally substituted C 1 -C 4 alkyl; R 3 and R 4 independently represent optionally identical substituents selected from hydrogen or optionally substituted C 1 -C 4 alkyl; R 5 represents an alkyl substituent selected from hydrogen, optionally substituted C 1 -C 7 alkyl, optionally substituted aryl, optionally substituted heterocyclyl, C 1 -C 4 alkoxycarbonyl, optionally substituted aminocarbonyl.
  • US5171746A
    申请人:——
    公开号:US5171746A
    公开(公告)日:1992-12-15
查看更多